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Multiple sclerosis (MS) is a major cause of neu-
rological disability in young adults and the most 
common chronic demyelinating disorder of the 
central nervous system (CNS; Noseworthy et al., 
2000). Our understanding of the cellular and 
molecular mechanisms mediating MS has been 
advanced by studies in the murine MS preclini-
cal model experimental autoimmune encepha-
lomyelitis (EAE). Development and progression 
of this and other autoimmune disorders com-
pletely depends on the dynamic nature of im-
mune cells, particularly their ability to migrate 
and to rapidly form an immune synapse (IS) 
with antigen-presenting cells. Upon stimulation, 
lymphocytes undergo marked actin-dependent 
changes in shape that are required for produc-
tive cellular interactions and movement during 
an immune response. The posttranslational modi-
fication of proteins triggered by TCR signaling 
is a fundamental requirement for successful IS 
formation and includes the convergence of sev-
eral signaling molecules at the plasma membrane. 
Conformational changes induced by protein 
phosphorylation affect function by modifying 
binding motifs essential for recruiting proteins 
into signaling networks or by placing enzymes 
within proximity to substrates (Pawson and Scott, 
1997). Both tyrosine (Thome and Acuto, 1995) 
and serine/threonine kinases (Matthews and 
Cantrell, 2006) have been reported to be key 
modulators during lymphocyte activation, and 
several novel small molecules designed to inhibit 
these kinases are currently under investigation in 
clinical trials involving patients with inflam-
matory and autoimmune disorders (Cohen, 2002).
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Cyclin-dependent kinase 5 (Cdk5) is a ubiquitously expressed serine/threonine kinase. 
However, a requirement for Cdk5 has been demonstrated only in postmitotic neurons where 
there is abundant expression of its activating partners p35 and/or p39. Although hyper-
activation of the Cdk5–p35 complex has been found in a variety of inflammatory neuro-
degenerative disorders, the potential contribution of nonneuronal Cdk5–p35 activity has not 
been explored in this context. We describe a previously unknown function of the Cdk5–p35 
complex in T cells that is required for induction of experimental autoimmune encephalo-
myelitis (EAE). T cell receptor (TCR) stimulation leads to a rapid induction of Cdk5–p35 
expression that is required for T lymphocyte activation. Chimeric mice lacking Cdk5 gene 
expression in hematopoietic tissues (Cdk5/C) are resistant to induction of EAE, and 
adoptive transfer of either Cdk5/C or p35/ encephalitogenic lymphocytes fails to 
transfer disease. Moreover, our data reveal a novel mechanism involving Cdk5-mediated 
phosphorylation of the actin modulator coronin 1a on threonine 418. Cdk5-deficient 
lymphocytes lack this posttranslational modification of coronin 1a and exhibit defective 
TCR-induced actin polarization and reduced migration toward CCL-19. These data define a 
distinct role for Cdk5 in lymphocyte biology and suggest that inhibition of this kinase may 
be beneficial in the treatment of T cell–mediated inflammatory disorders.
© 2010 Pareek et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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cells has not been established. In this paper, we 
provide the first demonstration that the Cdk5–p35 
complex is essential for T cell activation and for 
the induction of EAE. We have generated immune chimeric 
mice (Cdk5/C) by reconstituting WT mice with hematopoi-
etic progenitors from Cdk5-deficient mice embryos (Cdk5/) 
after lethal irradiation. Characterization of the Cdk5/C 
and p35/ mice shows that Cdk5 activity is dispensable for 
immune cell development and lineage differentiation. Using 
phosphoproteomics, we show that Cdk5 phosphorylates 
coronin 1a, a leukocyte-specific protein and actin modulator 
(Ferrari et al., 1999), at the threonine 418 residue within a 
critical actin binding domain. Furthermore, Cdk5-deficient 
lymphocytes lack this phosphorylation and are hyporespon-
sive to mitogenic signals, including TCR ligation, and also fail 
to migrate after CCL19 chemokine stimulation. Most impor-
tantly, we show the relevance of these observations by dem-
onstrating the reduced susceptibility of Cdk5/C mice to 
EAE. Encephalitogenic lymphocytes derived from either the 
Cdk5/C or p35/ mice fail to transfer disease to normal 
mice. These results establish Cdk5 as an essential regulator of 
lymphocyte activation and as a potential therapeutic target 
for autoimmune disorders, including MS.
RESULTS
Increased Cdk5–p35 expression in CNS mononuclear 
infiltrates in EAE
Deregulated Cdk5 activity triggers progressive neurodegen-
eration and neurofibrillary tangle formation in mice (Cruz 
and Tsai, 2004). Tau pathology associated with axonal loss 
during EAE is linked to up-regulation of Cdk5 activity   
(Schneider et al., 2004). Furthermore, proteomic analysis of 
chronic active plaques of MS patients has shown significantly 
increased expression of Cdk5 (Han et al., 2008). In agreement 
with these results, we also observed increased expression of 
p35 protein and of its cleaved product p25 in the lumbar spi-
nal cord and brain stem of mice with EAE (Fig. 1 A). To de-
termine the contribution of inflammatory cells to this process, 
Cyclin-dependent kinase 5 (Cdk5), a ubiquitously expressed 
proline-directed serine/threonine kinase, is mainly active in 
postmitotic neurons as a result of abundant expression of its 
obligate activating partners p35 and/or p39 in these cells. 
Cdk5 has been considered a neuron-specific kinase and nar-
rowly viewed as an essential regulator of neuronal function 
(Dhavan and Tsai, 2001). This perception has been supported 
by gene KO studies in which germ line deletion of the genes 
encoding either Cdk5 or p35 lead to inverted cortical neuro-
nal layering during brain development (Ohshima et al., 1996; 
Chae et al., 1997). Normal activity of Cdk5 is required for 
proper neuronal migration, synapse formation, and neuronal 
survival. However, aberrant or hyperactivation of Cdk5 is as-
sociated with severe neurodegenerative disorders including 
Alzheimer’s disease (Shelton and Johnson, 2004).
Recently, Cdk5–p35 has been linked with disease induction 
in nonneuronal lineages (Rosales and Lee, 2006), with examples 
which include malignant transformation in cancer (Strock et al., 
2006; Lin et al., 2007; Upadhyay et al., 2008), induction of in-
flammatory pain (Pareek et al., 2006), and other inflammation-
mediated disorders (Kitazawa et al., 2005). Neurons and immune 
cells share functional similarities, such as the ability to migrate 
and form a functional synapse with neighboring cells. Under-
standing that a common molecular mechanism may underlie 
the link between inflammation and distinct conditions such as 
neurodegeneration (Wyss-Coray and Mucke, 2002) and cancer 
(Coussens and Werb, 2002), we hypothesized that the enhanced 
Cdk5 activity observed in these conditions may actually reflect 
an essential role for Cdk5 in the immune cells that traffic to sites 
of disease.
Cdk5–p35 activity has been reported in human leukemic 
cell lines and is thought to play a role in monocytic differen-
tiation (Chen and Studzinski, 2001; Studzinski and Harrison, 
2003). However, a role for the Cdk5–p35 complex in the 
activation and function of normal nontransformed immune 
Figure 1.  Increased Cdk5 activity in the CNS of mice 
with EAE. Mice were sacrificed 4 wk after EAE induction.  
(A) Western blotting shows increased p35 and p25 in lysates 
of diseased lumbar spinal cord and brain stem. Data repre-
sent three independent experiments. (B) Quantitative PCR for 
Cdk5 and p35 transcripts shows an increase in mononuclear 
cells harvested from lumbar spinal cord and brain stem of 
affected mice. Data represent 10 pairs of mice (control) 
and 6 pairs of mice (EAE) of two independent experiments. 
(C and D) Cdk5 kinase activity assays were measured as -[32P] 
incorporation in the Cdk5-specific substrate neurofilament H 
(NF-H) peptide. Tissue lysates prepared from brain stem and 
lumbar spinal cord show a correlation between Cdk5 expres-
sion and kinase activity (C). Data represent three independent 
experiments. Specificity of Cdk5 kinase activity was con-
firmed using 10 µM roscovitine (C) and Cdk5/ embryo (D; 
E16.5) brain lysates as controls. All data are the mean ± SEM. 
**, P < 0.01, Student’s t test.JEM VOL. 207, October 25, 2010 
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having any adverse effect on lymphocyte viability (Fig. S1 B), 
and there was no adverse effect of roscovitine on the expres-
sion of Cdk5 and p35 protein levels (not depicted). It should 
be noted that in each kinase assay the activity of Cdk5 is nor-
malized on a per-milligram protein basis. Although it may 
also be informative to analyze the specific kinase activity on   
a per-mole basis, we observed a clear increase in Cdk5 kinase 
activity upon TCR stimulation.
Although roscovitine is viewed as a selective inhibitor of 
Cdk5 in the dose range used for these experiments (Mapelli 
et al., 2005), nonselectivity of this compound cannot be ruled 
out, as this is the case for many small molecule inhibitors of 
kinase activity. Therefore, we next tested the impact of Cdk5 
and p35 gene deletion on T cell activation. Germ line dele-
tion of the Cdk5 gene is associated with embryonic lethality 
in mice (Ohshima et al., 1996); thus, we generated Cdk5-null 
immune chimeric mice (Cdk5/C; Fig. S2). We observed a 
60–70% reduction in the proliferative response (as measured 
we isolated mononuclear cell infiltrates (including T cells, 
B cells, and macrophages) from these tissues and examined the 
level of Cdk5 and p35 transcript in these cells. Quantitative 
RT-PCR demonstrated an increase in both Cdk5 (10-fold) 
and p35 (fivefold) transcripts (Fig. 1 B). The observed increase 
in expression of Cdk5 and p35 correlated with a more than 
twofold elevation in Cdk5 activity in total tissue lysates col-
lected from brain stem and lumbar spinal cord (Fig. 1 C). 
Specificity of Cdk5 kinase activity in this assay was confirmed 
using Cdk5 WT and KO embryo (embryonic day [E] 16.5) 
brain lysates (Fig. 1 D). These results suggest a potentially im-
portant role for Cdk5 in the function of immune cells that 
may be necessary for induction of EAE.
Induction of Cdk5 activity is a requirement  
for lymphocyte activation
We next determined the presence and importance of this   
kinase during lymphocyte activation. Although both Cdk5 
and p35 were found in very low abundance in normal T cells, 
their mRNA and protein expression increased within the 
first 24 h after CD3/CD28 stimulation and remained ele-
vated until 48 h after stimulation (Fig. 2 A). Although mRNA 
expression of Cdk5–p35 was consistently high for up to 72 h, 
the levels of the Cdk5–p35 protein started to decline after 
48 h. This late reduction in the levels of Cdk5–p35 protein 
likely reflects an increase in their degradation, a process which 
is known to be calcium dependent. We also observed a two- 
to threefold increase in Cdk5 kinase activity within 24–72 h 
of CD3/CD28-mediated T cell activation (Fig. 2 B). Simi-
larly, a threefold increase in Cdk5 activity was observed in 
response to IL-7, a nonredundant cytokine required for T cell 
survival and development which is also implicated in MS 
(Lundmark et al., 2007; Fig. 2 C). This effect of IL-7 is en-
hanced in the presence of CD3/CD28 stimulation. Lastly, 
protein lysates prepared from total splenocytes (Fig. 2 D) or 
from CD4+ T cells (Fig. 2 E) collected from mice with EAE 
showed a three- to fourfold increase in Cdk5 activity. The 
restimulation of these lymphocytes in vitro with myelin oli-
godendrocyte glycoprotein (MOG) antigen further increased 
the activity of Cdk5 when assayed at 72 h. The specificity of 
Cdk5 kinase activity in these assays was confirmed using Cdk5 
WT and KO embryo (E16.5) brain lysates (Fig. 2 F).
To analyze, if the overall increase in Cdk5 activity ob-
served in these experiments is a result of the true increase in 
specific kinase activity of Cdk5 or merely a result of the in-
creased expression of Cdk5 and p35 protein, we repeated 
these experiments in the presence or absence of a pharmaco-
logic inhibitor of Cdk5 activity (roscovitine), which is known 
to inhibit Cdk5 activity (by competitive ATP binding) with-
out altering its protein expression. The total splenocytes or 
purified T cells were stimulated under different conditions 
in the presence or absence of roscovitine. T cells stimulated 
with CD3/CD28, PMA/ionomycin, or allogeneic dendritic 
cells showed a significant decline in their proliferation when 
treated with 10 µM roscovitine (Fig. S1 A). Results obtained 
from an MTT assay ruled out the possibility of roscovitine 
Figure 2.  Cdk5 activity is up-regulated in lymphocytes after TCR 
or antigen-specific stimulation. Total T cells were isolated from lymph 
node and spleen and then stimulated with CD3/CD28. (A) PCR and West-
ern blot analyses showed increased expression of both Cdk5 and p35 
upon stimulation. Data represent three independent experiments of six 
pairs of mice. (B–F) Cdk5 kinase activity was measured as -[32P] incorpo-
ration in the Cdk5-specific substrate NF-H peptide. (B) Cdk5 kinase activ-
ity in T cells was increased after stimulation with or without CD3/CD28. 
Data represent two independent experiments of six pairs of mice. (C) Ad-
dition of IL-7 alone or with CD3/CD28 further enhanced Cdk5 activity. 
Data represent eight pairs of mice. (D and E) Total splenocytes (D) or CD4+ 
T cells (E) collected after EAE induction and cultured with or without  
MOG (35–55) showed increased Cdk5 activity. Data are derived from three  
independent experiments with six to eight pairs of mice. (F) Specificity  
of Cdk5 kinase activity was confirmed by using Cdk5/ embryo (E16.5) 
brain lysates as a control. All data are the mean ± SEM. **, P < 0.01,  
one-way analysis of variance (ANOVA) followed by Student’s t test.2510 Cdk5 activity is required for T cell activation | Pareek et al.
in recipients of p35/ encephalitogenic lymphocytes (Fig. 4 E). 
This observation is supported by histopathology, which shows 
reduced inflammatory infiltrates within the spinal cord of re-
cipients of the p35/ encephalitogenic lymphocytes (Fig. 4 F). 
It is noteworthy that encephalitogenic lymphocytes require 
restimulation with IL-12 before adoptive transfer (Kroenke 
et al., 2008). Therefore it may be interesting to explore 
whether a Th17-favoring culture condition might restore the 
encephalitogenic potential to the Cdk5/ T cells.
Cdk5 directly phosphorylates coronin 1a at threonine 418
To identify potential biological substrates of the Cdk5 kinase 
in activated immune cells during EAE, we collected lympho-
cytes from Cdk5+/+C and Cdk5/C mice 4 wk after MOG 
immunization. Deletion of Cdk5 in these cells was confirmed 
by performing Cdk5-specific RT-PCR (not depicted) and 
Western blotting (Fig. 5 A). The mitotic protein monoclonal 
2 (MPM-2)–specific antibody, which is known to recognize 
phosphorylated proline-directed serine/threonine residues in 
proteins (Yaffe et al., 1997), was used to analyze the impact of 
Cdk5 deletion on proline-directed serine/threonine phos-
phorylation in lymphocytes. We observed multiple bands with 
low abundance on our Western blot in Cdk5/C lympho-
cytes compared with Cdk5+/+C lymphocytes (Fig. 5 B). Anal-
ysis of these bands with liquid chromatography–tandem mass 
spectrometry and Mascot database search identified a 51-kD 
band as coronin 1a (a leukocyte-specific protein) with se-
quence coverage of 63% (Fig. S4 A) and a Mascot search score 
of 3557. Our liquid chromatography–tandem mass spectrom-
etry findings clearly confirmed phosphorylation of coronin 1A 
by 3H-thymidine uptake) of Cdk5/C (Fig. 3 A) or p35/ 
T cells (collected from p35/ mice; Fig. 3 B) to CD3/CD28 
stimulation, suggesting an essential requirement for Cdk5 ac-
tivity in T cell activation. To determine the potential relevance 
of this observation in the EAE model, we collected lympho-
cytes 4 wk after MOG (35–55)/CFA immunization and sub-
sequently cultured them either in the presence or absence of 
33 µg/ml MOG and/or 10 µM roscovitine. These MOG-
primed lymphocytes harvested from immunized WT mice 
exhibited a robust proliferative response when restimulated 
in vitro with MOG antigen and this effect was completely sup-
pressed by roscovitine treatment (Fig. S1 C). More impor-
tantly, encephalitogenic lymphocytes harvested from either 
the  MOG-immunized  Cdk5/C  mice  (Fig.  3  C)  or  the 
MOG-immunized p35/ mice (Fig. 3 D) did not respond 
when reexposed to MOG in vitro. Interestingly, we observed 
a gene dose effect for p35 in these experiments. Proliferation 
after restimulation with MOG in vitro was reduced by 50% 
in p35+/ lymphocytes and by 70% in p35/ lymphocytes 
relative to p35+/+ controls. This represents the first demon-
stration of true haploinsufficiency for p35.
Disruption of Cdk5 or p35 gene expression ameliorates 
clinical signs of EAE
We next analyzed the susceptibility of Cdk5/C and p35/ 
mice to EAE. During the first 4 wk after immunization, the sur-
vival of Cdk5/C mice (75%) was significantly greater than that 
of either the Cdk5+/+C mice or C57Bl6+/+C mice (radiation 
control) in whom survival was <25% as a result of the severity of 
disease (Fig. 4 A). There was also a significant delay in the devel-
opment  and  a  reduction  in  the  clinical  severity  of  EAE  in 
Cdk5/C mice (Fig. 4 B). Histological examination of brain and 
spinal cord of Cdk5/C mice also revealed significantly less in-
flammation, demyelination, and axonal loss (Fig. 4 C). Immuno-
histochemical analysis of the immune infiltrates in the CNS 
demonstrated a significant reduction in the numbers of T cells, 
macrophages, and neutrophils in Cdk5/C mice (Fig. S3).   
In contrast, there was no significant difference in either disease 
progression or disease severity among genotypes when EAE was 
induced in p35+/+, p35+/, and p35/ mice (not depicted), de-
spite the objective differences in the proliferative response of 
lymphocytes reexposed to MOG in vitro (Fig. 3). It is important 
to note that there are significant defects in neuronal development 
in p35/ mice, and these mice have a shorter life span (Chae   
et al., 1997). Thus, interpretation of the results of MOG immu-
nization in the p35/ mice may be complicated either by the 
ability of p39 to compensate for disruption of p35 or by the un-
derlying CNS disease that enhances susceptibility to EAE.
To obviate the impact of these variables that exist in the 
p35/ model, as well as the potential influence of the radiation 
required for establishing the Cdk5 chimeric mice, we next used 
an adoptive transfer approach, assessing the ability of encepha-
litogenic lymphocytes from these models to transfer disease 
to naive animals. Lymphocytes harvested from immunized 
Cdk5/C mice completely failed to transfer disease (Fig. 4 D). 
More importantly, disease progression was significantly delayed 
Figure 3.  Disruption of Cdk5 activity abrogates antigen receptor-
mediated lymphocyte activation. Lymphocyte activation and prolifera-
tion were measured by 3H-thymidine incorporation. (A and B) Cdk5+/+C 
and Cdk5/C (A) and p35+/+ and p35/ (B) T cells were isolated and  
activated with CD3/CD28. (C and D) Lymphocytes were collected from 
Cdk5+/+C and Cdk5/C (C) and p35+/+, p35+/, and p35/ (D) mice 4 wk 
after EAE induction and stimulated in vitro with MOG. Each data set is 
derived from a minimum of four independent experiments with four to 
six pairs of mice. All data are mean ± SEM. **, P < 0.01; ***, P < 0.001, 
one-way ANOVA followed by Student’s t test.JEM VOL. 207, October 25, 2010 
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phosphorylation of threonine 418 
was observed in Cdk5/C lympho-
cytes and was confirmed by se-
lected ion chromatography (Fig. 5 D). 
However, Western blot analyses for 
total coronin 1a protein showed 
identical expression in Cdk5+/+C and 
Cdk5/C lymphocytes (Fig. 5 C), 
demonstrating that this posttrans-
lational modification does not af-
fect the abundance of coronin 1a.
To determine whether coronin 
1a is a direct substrate for Cdk5, 
coronin 1a was immunoprecipi-
tated from lysates of Cdk5+/+C and 
Cdk5/C encephalitogenic lym-
phocytes.  Total  immunoprecipitates  were  then  assayed  by 
Western blotting with both Cdk5 and coronin 1a antibodies 
(Fig. 5 E). The results suggest a direct association of Cdk5 
and coronin 1a in lymphocytes. Next, to identify if Cdk5 can 
directly  phosphorylate  coronin  1a,  immunoprecipitates  of 
coronin 1a obtained from normal lymphocytes were mixed 
with active Cdk5 complex obtained from Cdk5+/+ embryo 
brain lysates and then subjected to in vitro kinase assays in the 
and pinpointed the phosphorylation site at threonine 418. 
A total of two phosphopeptides containing this phosphoryla-
tion site were detected and their sequences are  415RRAT-
PEPSGTPSSDTVSR432 and 416RATPEPSGTPSSDTVSR432. 
The tandem mass spectrometry spectrum of peptide 416–432 
is shown in Fig. S4 B. We further analyzed the status of threo-
nine 418 phosphorylation in both Cdk5+/+C and Cdk5/C 
encephalitogenic lymphocytes. A threefold reduction in 
Figure 4.  Abrogation of Cdk5 activity 
in lymphocytes ameliorates clinical 
signs and associates with reduced pa-
thology in EAE. (A and B) Cdk5+/+C, 
Cdk5/C, and C57Bl6+/+C mice were immu-
nized with MOG to induce EAE and rou-
tinely observed for survival (Kaplan-Meier 
survival curve; A) and for development of 
clinical signs of EAE (B). Data represent 
three independent experiments with a total 
of 26 pairs of mice. (C) 4 wk after induction 
of EAE, mice were sacrificed and spinal 
cord was processed and stained with he-
matoxylin and eosin to assess inflamma-
tion, with Luxol fast blue to analyze 
demyelination, and with Bielschowsky stain 
to measure axonal loss (each indicated by 
arrows). Bars, 200 µm. Data represent three 
independent experiments. (D–F) C57BL6 
WT mice received encephalitogenic lym-
phocytes from either Cdk5+/+C or Cdk5/C 
mice (D) or from p35+/+, p35+/, and 
p35/ mice (E) and were observed closely 
for the development of clinical signs of 
EAE. Data represent two independent ex-
periments with nine pairs of mice. Error 
bars are mean ± SEM. (F) Lumbar spinal 
cord from mice receiving either p35+/+ or 
p35/ encephalitogenic immune cells was 
removed and stained with hematoxylin 
and eosin to evaluate for inflammation 
(arrows). Bars, 200 µm. Data represent two 
independent experiments.2512 Cdk5 activity is required for T cell activation | Pareek et al.
from the C57BL6+/+C, Cdk5+/+C, and Cdk5/C mice. Inter-
estingly, Cdk5+/+C encephalitogenic lymphocytes exhibited a 
distinct polarization of F-actin and coronin 1a, with most of 
the coronin 1a clustered on the pole directly opposite of 
F-actin clustering, and this phenomenon was completely lost 
in Cdk5/C encephalitogenic lymphocytes (Fig. 6, C and D). 
In contrast, Arp2/3 polarization was not compromised in 
Cdk5/C encephalitogenic lymphocytes (Fig. S5). These re-
sults support an essential role for Cdk5-mediated coronin 1a 
phosphorylation in actin dynamics, revealing an important 
mechanism through which Cdk5 may control both T cell ac-
tivation and migration.
Several chemokines and their receptors have been shown 
to play a major role in the recruitment of lymphocytes to 
the CNS during EAE (Proudfoot et al., 2008). Moreover 
coronin 1a–deficient lymphocytes fail to migrate toward 
CCL19 (Föger et al., 2006). Therefore, we next analyzed the 
impact of either pharmacologic inhibition or genetic deletion 
of Cdk5 on lymphocyte migration toward the chemokine 
CCL19. In transmigration assays, there was a 55% reduction 
in the migration of Jurkat cells toward CCL19 (MIP3-) and 
10-fold decrease in migration toward of SDF1 and SDF1 
(CXCL12) in the presence of 10 µM roscovitine (Fig. S6). 
presence of -[32P]ATP. Autoradiographs of the kinase assay 
products clearly show that Cdk5 directly phosphorylates 
coronin 1a (Fig. 5 F). To confirm the relative importance 
of threonine residues identified by mass spectrometry analysis, 
we synthesized 17-mer coronin 1a peptides (416–432) and 
replaced threonine 418 and/or threonine 424 with alanine 
(Fig. 5 G). These peptides were then used in an in vitro kinase 
assay as substrates for Cdk5. All three mutations were associ-
ated with a significant reduction in Cdk5-mediated phosphory-
lation of the coronin 1a peptide compared with WT, with 
threonine 418 being most important (Fig. 5 G).
Disruption of Cdk5 activity impairs actin polarization  
and migration of lymphocytes to specific chemokine signals
Genetic deletion of coronin 1a in mice established the abso-
lute requirement of this protein in T cell antigen receptor 
function (Föger et al., 2006). Coronin 1a has been shown to 
bind directly to F-actin in vitro and to colocalize with F-actin 
structures in vivo (de Hostos et al., 1991). To determine the 
impact of Cdk5-mediated coronin 1a phosphorylation on 
F-actin and coronin 1a association, we collected lymphocytes 
from C57BL6+/+C, Cdk5+/+C, and Cdk5/C mice after EAE 
induction. As expected, both normal (Fig. 6 A) and control 
(Fig. 6 B) lymphocytes showed homogeneous colocalization 
of coronin 1a and F-actin with slight polarization in control 
cells but no discernible difference among lymphocytes isolated 
Figure 5.  Cdk5 physically interacts with and 
phosphorylates coronin 1a. (A–C) Protein lysates 
were prepared from lymphocytes collected 10 d after 
EAE induction in Cdk5+/+C and Cdk5/C mice and 
Western blots were probed with anti-Cdk5 (A),  
–MPM-2 (B), and –coronin 1a (C) antibodies. Data 
represents three independent experiments with six to 
eight pairs of mice. (D) Coronin 1a–threonine 418 
phosphorylation of Cdk5+/+C and Cdk5/C encephali-
togenic lymphocytes as confirmed by selected ion 
chromatography. Data represent six pairs of mice of 
two independent experiments. (E) Coronin 1a protein 
was immunoprecipitated from Cdk5+/+C and Cdk5/C 
encephalitogenic lymphocytes and Western blotting 
was performed using antibodies against Cdk5 (top) 
and coronin 1a (bottom). Data represent three inde-
pendent experiments. (F) Coronin 1a immunoprecipi-
tated from normal lymphocytes was used as a 
substrate for Cdk5 in a kinase assay. The top depicts 
the autoradiograph of phosphorylated coronin 1a by 
Cdk5 and the bottom is the Coomassie blue stained 
gel showing total coronin 1a used in the kinase reac-
tion. Data represent three independent experiments. 
(G) Coronin 1a peptide harboring amino acid se-
quence of WT protein from 416–432 (418T and 424T) 
or mutant peptide where threonine was replaced 
with alanine or aspartate. Data represent five inde-
pendent experiments. (H) Cdk5-mediated coronin 1a 
WT or mutant peptide phosphorylation was measured 
through -[32P] incorporation. Cdk5 used in this ki-
nase assay was collected from mouse embryo brain 
and Cdk5 KO brain served as control. Data represent 
three independent experiments. All data are the 
mean ± SEM. **, P < 0.01; *, P < 0.05, one way ANOVA 
followed by Student’s t test.JEM VOL. 207, October 25, 2010 
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Figure 6.  Disruption of Cdk5 activity diminishes actin polarization and migration toward CCL19. (A–C) Cdk5+/+C, Cdk5/C, and C57BL6+/+C mice 
were immunized with PBS (normal; A), CFA + pertussis toxin (PTX; control; B), or MOG(35–55) + CFA + PTX (EAE; C) and, 4 wk later, lymphocytes were col-
lected and stained for F-actin using phalloidin (red) and coronin 1a (green) antibody. The white arrows indicate polarization of F actin and the yellow arrows 
indicate polarization of coronin 1a on the opposite end. (D) These polarized cells were counted from six different regions by a person blinded to sample 
identity. The data represent two independent experiments of six pairs of mice. (E) The number of cells harvested from the lower chamber containing 100 ng 
CCL19 in transmigration assays, where the upper chamber contains primary lymphocytes collected from either Cdk5+/+C or Cdk5/C mice. Bars, 100 µm. 
Data represent three independent experiments of five pairs of mice, mean ± SEM. ***, P < 0.001, one way ANOVA followed by Student’s t test.2514 Cdk5 activity is required for T cell activation | Pareek et al.
Finally, migration of Cdk5/C lymphocytes toward CCL19 
was significantly reduced when compared with migration of 
Cdk5+/+C control lymphocytes (Fig. 6 E). Collectively, these 
results suggest that Cdk5-mediated coronin 1a phosphorylation 
is required for proper lymphocyte activation and migration.
DISCUSSION
More than a century after the first description of the clinical 
and pathological characteristics of MS (Pearce, 2005), we have 
gained immense knowledge regarding the potential molecu-
lar and cellular mechanisms mediating disease pathogenesis. 
Aberrant activation of immune cells is a major hallmark of 
this autoimmune disease. Thus, therapeutic efforts in MS pa-
tients have been largely directed toward suppression of the 
activated immune system. The initiation of the immune cell 
response requires dynamic processing of the actin cytoskele-
ton and involves the recruitment of different proteins within 
the cell to form the IS, enabling the cell to migrate toward   
a specific chemokine signal. Several protein kinases have been 
implicated in this process, but how these proteins collaborate 
to enable lymphocyte activation and promote the genesis of 
an autoimmune response has not been fully elucidated.
In the current study, we explore the role of Cdk5 in im-
mune cells. Our current knowledge suggests that kinase ac-
tivity of ubiquitously expressed Cdk5 is mainly restricted to 
postmitotic neurons as a result of the predominant expression 
of its activating partner proteins p35 and p39 in these cells. 
However, the abundance of Cdk5 expression in nonneuronal 
cells argues against a functional irrelevance of Cdk5 in these 
lineages and, rather, points to a potentially important role for 
this kinase in their normal cell physiology. It is likely that Cdk5 
is recruited or activated by cells in response to external stimuli 
that either influence their state of activation or trigger a differ-
entiated function such as the secretion of cytokines or cell mi-
gration. In this context, the absence of Cdk5 kinase activity 
in nonneuronal cells may not impair normal development or 
distribution of cells but, rather, affect cellular events that are 
required for host responses to harmful stimuli or to an exter-
nal challenge.
The relevance of Cdk5 kinase activity in immune cells 
has not been extensively studied. However, there are several 
common signaling partners among neurons and immune cells 
that are participants in the control of gene transcription and 
cytoskeletal architecture, and the Cdk5-mediated phosphory-
lation of these proteins is known to modulate their function 
in neurons. The dependency of these proteins on Cdk5 func-
tion in immune cell signaling has not been explored. For 
example, Cdk5-mediated phosphorylation induces STAT3 
transcriptional activity (Fu et al., 2004) and suppresses MEF2-
mediated transcription (Gong et al., 2003) in neurons, and 
both of these transcription factors are critical regulators of   
T cell (Lu et al., 2008) and B cell (Wilker et al., 2008) activa-
tion. Moreover, Cdk5 is known to modulate actin dynamics 
in neurons through phosphorylation of proteins involved in 
maintaining cytoskeletal architecture and promoting neuro-
nal migration such as the ERM protein ezrin (Yang and Hinds, 
2003), WAVE1 (Kim et al., 2006), WAVE2 (Miyamoto et al., 
2008), FAK (Xie et al., 2003), and also Rac and Pak (Nikolic 
et al., 1998; Rashid et al., 2001). These proteins are similarly 
known to regulate reorganization of the actin cytoskeleton in 
immune cells during TCR signaling, lymphocyte differentia-
tion, and migration and also to orchestrate effector function 
(Burkhardt et al., 2008). Posttranslational modification of these 
proteins by their phosphorylation is known to regulate cyto-
skeletal dynamics in immune cells (Kurosaki and Hikida, 2009; 
Prince et al., 2009; Salmond et al., 2009). However, the func-
tional relevance of Cdk5 in modulating cytoskeletal proteins 
during lymphocyte activation has not been explored.
The results presented herein suggest that Cdk5 is a non-
redundant kinase in immune cells whose activity is required 
for lymphocyte activation. When total lymphocytes or puri-
fied T cells are activated in vitro by antigenic stimulation or 
by TCR ligation, they demonstrate a significant increase in 
Cdk5 activity. It is important to note that the up-regulation 
of Cdk5 activity observed in lymphocytes of MOG/CFA-
immunized mice is not seen after immunization with CFA 
alone. The most likely explanation for this difference is that 
CFA alone induces only a transient activation of lymphocytes 
that wanes within 3 wk, unlike the sustained adaptive lym-
phocyte response to MOG. Regardless, it may be informa-
tive to see whether there is a short-term induction of Cdk5 
activity (either local or systemic) after exposure to CFA alone 
and, if so, to explore whether this plays a role in the establish-
ment of disease in this model.
Furthermore, pharmacologic suppression of Cdk5 activity 
or targeted disruption of Cdk5–p35 gene expression impairs 
the lymphocyte response to TCR ligation or antigenic stimu-
lation. Hematopoietic organs of Cdk5/ embryos develop 
normally, and there are no obvious phenotypic differences in 
either the number or ratio of immune cell populations in 
either Cdk5/ or p35/ mice compared with their WT lit-
termates (Fig. S2, D and F–H). Similarly, immunophenotyping 
of the Cdk5+/+C and Cdk5/C mice shows no differences in 
gross anatomical structure, cellularity, or lineage distribution 
in hematopoietic organs (bone marrow, spleen, thymus, and 
lymph nodes; Fig. S2 E). However, when these mice are chal-
lenged  through  induction  of  EAE,  the  spleen  and  lymph 
nodes of Cdk5/C mice are significantly smaller with the 
substantial reduction in tissue weight, cellularity, and disorga-
nized tissue architecture compared with the Cdk5+/+C control 
mice (unpublished data). Thus, although Cdk5/C naive 
lymphocytes develop normally, their coordinated response to 
antigenic stimuli is hampered as demonstrated by the delayed 
development and reduced severity of EAE.
Interestingly,  Cdk5/C  encephalitogenic  splenocytes, 
collected either during the active phase (10 d after EAE in-
duction) or chronic phase (21 d after EAE induction) of EAE, 
show significant reduction in the production of IL-2, IL-6, 
IL-17, TNF, and GM-CSF, when compared with Cdk5+/+C 
cells, after restimulation with MOG antigen in vitro. We did 
observe a significant drop in IFN- cytokine production 
from these cells during active phase but the difference was JEM VOL. 207, October 25, 2010 
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In summary, Cdk5 now joins a growing list of proteins that 
were first discovered in the nervous system, such as Dscam and 
semaphorins, that have since been found to have an important 
function in immune cells (Boulanger, 2009). This study provides 
novel insight into the regulation of lymphocyte activation and 
function through Cdk5-mediated coronin 1a phosphorylation. 
This discovery of an important extraneuronal role for Cdk5 as   
a biochemical intermediate in T cell signaling expands the 
repertoire of nonneuronal activities for a molecule that was pre-
viously assigned to a predominantly lineage-restricted function 
in the CNS. Our results have implications for several neurode-
generative and mental health disorders, wherein immune- 
mediated activation of Cdk5 may contribute to the predisposition 
and pathogenesis of diseases including MS. These data establish   
a new paradigm that links activation of Cdk5 in immune cells to 
the pathogenesis of disorders associated with inflammation and 
provide a strong rationale for the development and clinical evalua-
tion of novel inhibitors of Cdk5 in the context of immune- 
mediated diseases such as MS.
MATERIALS AND METHODS
Animals. 6–8-wk-old C57BL/6 or B6D21 mice were purchased from The 
Jackson Laboratory and used for collection of lymphocytes or allogeneic 
APC  collection  and  EAE  induction.  B6-Ly5.2Cr  mice  (referred  to  as 
CD45.1+)  were  purchased  from  the  National  Cancer  Institute  (Charles 
River Laboratories) and used for generation of chimeric mice. Cdk5+/ 
mice were used to generate Cdk5+/+ and Cdk5/ embryos, which were 
further used for collection of brain or hematopoietic cells. 3-mo-old p35+/+, 
p35+/, or p35/ mice were used for lymphocyte collection and for induc-
tion of EAE. All animals were housed in microisolator cages and maintained 
in climate- and light-controlled rooms (22 ± 0.5°C, 12/12-h dark/light   
cycle) with free access to food and water. Studies were performed in compli-
ance with procedures approved by the Case Western Reserve University 
School of Medicine’s Institutional Animal Care and Use Committee.
Generation of Cdk5-null immune chimeric mice. Hematopoietic cells 
were collected from liver and spleen of E16.5 Cdk5+/+ and Cdk5/ litter-
mate embryos, all offspring of male and female Cdk5+/ breeder mice.   
Approximately 10 million cells per mouse were then injected into 12-wk-old   
lethally irradiated (1,400 rad; Gammacel 137Cs; J.L. Shepard & Associates) 
CD45.1 female mice by tail vein injection. 8 wk later, peripheral blood was 
collected from all recipients and tested for CD45.1 versus CD45.2 expression 
by flow cytometry and PCR analysis for Cdk5 using the following primers: 
5-TGAGGGTGTGCCAAGTTCAGC-3 and 5-GGCATTGAGTTTGG-
GCACGAC-3. These Cdk5 WT and Cdk5-null immune chimeric mice 
were further recognized as Cdk5+/+C and Cdk5/C, respectively. C57BL/6 
chimeras were generated by injecting lethally irradiated CD45.1 mice with 
8 × 106 bone marrow cells isolated from 10–12-wk-old C57BL/6 female mice 
and recognized as C57BL6+/+C. Upon establishment of chimeric mice, these 
lines were then maintained by transferring 8 × 106 bone marrow cells from 
each subsequent generation into lethally irradiated CD45.1 female mice. 
Cdk5 chimeric mice were maintained for a maximum of three generations.
EAE induction. EAE was induced in mice by MOG (35–55) immuniza-
tion and disease was adoptively transferred to unaffected WT animals as   
previously described (Mi et al., 2007). In brief, Cdk5+/+C, Cdk5/C, and 
C57BL6+/+C or p35+/+, p35+/, and p35/ mice were immunized with sub-
cutaneous injections on both flanks with 200 µl of emulsion containing either 
CFA consisting of 100 µl of incomplete Freund’s adjuvant with 8 mg/ml Myco-
bacterium tuberculosis and 100 µl PBS (DIFCO Laboratories) or CFA with 200 µg 
MOG (35–55). At the time of injection and 48 h later, 200 ng PTX (List 
Biological Laboratories) was injected intraperitoneally in 100 µl PBS and 
not significant in chronic phase (Fig. S7). The observed dif-
ference in cytokine production may reflect a reduction in the 
number of MOG-specific T cells, impaired TCR stimula-
tion, or a skewing in the differentiation of Cdk5/C lympho-
cytes. Regardless, the observed reduction in Th1 and Th17 
cytokines production provides a plausible explanation for the 
reduced severity of disease in these mice.
The  phosphoproteomic  studies  described  herein  show 
that Cdk5-dependent modulation of immune cell function is 
partially mediated through the posttranslational modification 
of coronin 1a. Coronin is a conserved actin binding protein that 
promotes different cellular processes that rely on rapid remod-
eling of the actin cytoskeleton (Clemen et al., 2008). Deletion 
of the coronin 1a gene in mice is associated with alterations in 
cellular steady-state F-actin formation in lymphocytes (Föger 
et al., 2006) and reductions in lymphocyte survival, migration, 
and Ca2+ release from intracellular stores (Mueller et al., 2008). 
Coronin 1a gene deletions are associated with severe combined 
immunodeficiency in humans (Shiow et al., 2008, 2009), and 
nonsense mutation of the coronin 1a gene (Lmb3 locus) pro-
tects against the induction of systemic lupus in mice (Haraldsson 
et al., 2008). The crystal structures of a C-terminal truncated 
form of coronin 1a (residues 1–402), along with a C-terminal 
fragment (residues 430–461), have been solved (Appleton et al., 
2006); however, the structure information with respect to 
residues 403–429, which contains the Cdk5-targeted threo-
nine 418 phosphorylation site, has not been resolved. It is 
noteworthy that this domain contains a linker region (resi-
dues 356–429) of this protein, which is considered essential 
for interaction of the coronin 1a homotrimer complex with 
cytoskeleton (Gatfield et al., 2005). In this paper, we report 
for the first time that Cdk5 directly phosphorylates coronin 1a 
on threonine 418. It is quite possible that phosphorylation of 
threonine 418 is required for the association of a positively 
charged stretch of linker region with F-actin. Interestingly, 
Pho85, a functional homologue of Cdk5 in budding yeast 
(Huang et al., 1999), has been shown to phosphorylate yeast 
coronin 1 on multiple sites (Gandhi and Goode, 2008). In the 
current study, we demonstrate that coronin 1a is directly asso-
ciated with and is phosphorylated by Cdk5 and that this 
phosphorylation is required for F-actin nucleation but not for 
Arp2/3 polarization in activated lymphocytes during EAE.
Finally, specific chemokine receptors have been impli-
cated in MS and their roles have been demonstrated in the 
EAE model (Karpus and Ransohoff, 1998). In addition to 
regulating lymphocyte homing to secondary lymphoid tissue, 
the chemokine CCL19 participates in the pathophysiology of 
EAE by controlling T cell migration into the CNS (Alt et al., 
2002). Similar to coronin 1a KO lymphocytes (Föger et al., 
2006), either the pharmacologic suppression or genetic deletion 
of Cdk5 in lymphocytes impairs migration toward CCL19. 
Whether these results are a direct and specific consequence of 
altered Cdk5-mediated phosphorylation of coronin 1a re-
mains to be proven, and thus future studies will explore the 
functional consequences of Cdk5-mediated phosphorylation 
of coronin 1a on threonine 418.2516 Cdk5 activity is required for T cell activation | Pareek et al.
protein A–Agarose beads and then incubated overnight with anti–hamster 
coronin 1a antibody at 4°C. On the next day, lysates were incubated for an 
additional 4 h at 4°C with 50 µl of a 50% protein A–Agarose bead slurry pre-
pared in lysis buffer. After incubation, the protein A–Agarose beads were spun 
down and washed three times with lysis buffer and then subjected to Western 
blot analysis by using antibody against Cdk5 (C-8) and coronin 1a (anti– 
rabbit coronin 1a).
Cdk5 kinase activity assay. Cdk5 kinase activity assays were performed as 
described earlier (Pareek et al., 2007). In brief, tissue or cell lysates were pre-
pared in RIPA buffer containing a protease inhibitor tablet (Roche) and the 
phosphatase inhibitor cocktails I and II (Sigma-Aldrich). Protein lysates (500 µg 
of lumbar spinal cord, brain stem, or embryo brain lysates or 1 mg of spleen, 
lymphocyte, or T cell lysates) were dissolved in lysis buffer to achieve a 1-µg/µl 
concentration and then precleared with normal rabbit IgG followed with   
50–100 µl of 50% protein A–Agarose slurry (Sigma-Aldrich) prepared in lysis 
buffer. These lysates were then incubated overnight at 4°C with 0.01 µg/µl of 
anti-Cdk5 IgG. On the next day, lysates were subjected to a 3-h incubation 
with 50 µl of a 50% protein A–Agarose slurry at 4°C. Immunoprecipitates 
were washed three times with lysis buffer followed with kinase buffer (20 mM 
Tris-HCl, pH 7.4, 10 mM MgCl2, 1 mM EDTA, 10 µM NaF, and 1 µM 
Na2VO3) and resuspended in 10 µl of 5× kinase assay mixture (100 mM Tris-
HCl, pH 7.4, 50 mM MgCl2, 5 mM EDTA, 50 µM NaF, 5 µM Na2VO3, and 
5 mM DTT), 30 µl of water, and 20 µM of either the NF-H peptide or im-
munoprecipitated coronin 1a or coronin 1a peptides (WT or mutant 1, 2, or 3). 
Samples were kept at 30°C for 60 min after adding 5 µCi -[32P]ATP   
(0.5 mM), and the reaction was stopped by adding 10% trichloroacetic acid in 
peptide kinase assay buffer and by adding sample buffer (2% SDS, 10% glyc-
erol, 80 mM Tris, pH 6.8, and 1 mM DTT) and boiling for the 10 min for the 
coronin 1a kinase reaction. To detect coronin 1a phosphorylation, 20-µl ali-
quots were electrophoresed on a 10% polyacrylamide gel, which was then 
stained with Coomassie blue, destained, dried, and exposed overnight to a 
phosphoscreen. The phosphoscreen was scanned on a Storm PhosphorImager 
(Molecular Dynamics). For peptide kinase assay, supernatants were collected 
and spotted in triplicate onto P81 phosphocellulose squares, air dried, and 
washed five times with 75 mM phosphoric acid and once in 95% ethanol. 
Phosphocellulose squares were then soaked in ultima gold liquid scintillation 
buffer (PerkinElmer), and the incorporated -[32P] was counted on a Micro-
Beta TriLux (PerkinElmer) as a measurement of Cdk5 activity.
Lymphocyte and T cell isolation. Mononuclear cells infiltrating mouse 
CNS tissues were collected by discontinuous percoll gradient as previously 
described (Cua et al., 2003). Total lymphocytes were collected from spleen 
and regional lymph nodes (axillary, branchial, and inguinal) by passing 
minced tissues through a 40-µm cell strainer (BD) and thereafter incubating 
with ACK lysing buffer (Lonza) on ice for 5 min to deplete erythrocytes. For 
further purification, these cells were then subjected to MACS separation 
columns using a pan T isolation kit (Miltenyi Biotec), as per the manufacturer’s 
protocol, to isolate total T cells.
Thymidine assay of cell proliferation. Total lymphocytes or T cells 
were stimulated with CD3/CD28, PMA-ionomycin, allogeneic dendritic 
cells, or MOG (35–55) for 72 h in a 96-well plate in RPMI-1640 culture 
media (Invitrogen) containing 50 µM 2-mercaptoethanol and 10% fetal bo-
vine serum. During the last 16–18 h of culture, 1 µCi 3H-thymdine was 
added to each well and cells were harvested on a Unifilter-96 Harvester 
(Perkin Elmer). Incorporation of 3H-thymdine was measured as counts per 
minute on a 1450 MicroBeta TriLux (Perkin Elmer).
Histology.  Histology  and  immunocytochemical  localization  were  per-
formed as described previously (Pareek et al., 2006). In brief, 4–6 wk after 
EAE induction, mice were anesthetized and perfused with PBS followed 
with 4% paraformaldehyde in PBS (PFA-PBS). Spinal cords were collected 
and fixed in 4% PFA-PBS and embedded in paraffin to obtain 5-µm-thick 
sections. The spinal cord was divided into four parts (cervical, thoracic, lumbar, 
mice were monitored daily for clinical signs of EAE. For adoptive transfer of 
EAE, Cdk5+/+C and Cdk5/C or p35+/+, p35+/, and p35/ mice were 
euthanized 10 d after MOG (35–55) immunization and cell suspensions 
were prepared from spleen and regional lymph nodes (axillary, branchial, 
and inguinal). About 5 × 106 cells were cultured in the presence of 33 µg/ml 
MOG (35–55) and 20 ng/ml of mouse IL-12. 3 d later 2–3 × 107 of the 
cultured encephalitogenic cells were then injected into 3-mo-old female 
C57BL6 mice via intraperitoneal injection. 200 ng PTX was injected on the 
same day and again 48 h later. The following criteria were used to grade 
clinical scores: 0, no signs of disease; 1, limp tail; 2, moderate hind limb 
weakness; 3, severe hind limb weakness; 4, complete hind limb paralysis; 5, 
quadriplegia or premoribund state; 6, death.
Peptide synthesis. The following peptides were used in this study: MOG 
(35–55) peptide, MEVGWYRSPFSRVVHLYRNGK; NF-H peptide, VK-
SPAKEKAKSPVK; coronin 1a WT, RATPEPSGTPSSDTVSR; coronin 1a 
mutant 1, RAAPEPSGTPSSDTVSR; coronin 1a mutant 2, RATPEPS-
GAPSSDTVSR; and coronin 1a mutant 3, RAAPEPSGAPSSDTVSR. All 
peptides were synthesized at 21st Century Biochemical using Fmoc chemis-
try and were HPLC purified to a minimum >90%, and the mass and se-
quence were verified by nanospray mass spectrometry and collision-induced 
dissociation tandem mass spectrometry.
Antibodies.  The  anti-Cdk5  antibody  (C-8),  anti-p35  antibody  (C-19; 
Santa Cruz Biotechnology, Inc.), and MPM-2 antibody (Millipore) were 
each used at 1:200 dilution for Western blots. 5 µg of the anti-Cdk5 anti-
body (C-8) was used for immunoprecipitation. Hamster monoclonal anti–
coronin 1a antibody was provided by A.C. Chen (Genentech, San Francisco, 
CA) and used at a 1:1,000 dilution for Western blotting and a 1:200 dilution 
for immunoprecipitation. Rabbit polyclonal anti–coronin 1a serum was pro-
vided by J. Pieters (University of Basel, Basel, Switzerland) and used for 
Western blotting at a 1:5,000 dilution and for immunohistochemistry at a 
1:500 dilution. Alexa Fluor 568 phalloidin (Invitrogen) was used to detect 
F-actin at a 1:25 dilution. Horseradish peroxidase–conjugated anti–hamster 
(BD) was used as a secondary antibody at 1:5,000 and horseradish peroxidase–
conjugated anti–mouse and anti–rabbit antibodies (Jackson ImmunoResearch 
Laboratories, Inc.) were used at a 1:10,000 dilution for Western blots. The 
secondary antibodies anti–rabbit Alexa Fluor 488, anti–mouse Alexa Fluor 546, 
and anti–mouse Alexa Fluor 633 (Invitrogen) were used at a 1:200 dilution 
for immunofluorescence.
Roscovitine. All roscovitine (C19H26N6O; 6-Benzylamino-2-(R)-((1-ethyl)- 
2-hydroxyethylamino)-9-isopropylpurine;  2(R)-(1-Ethyl-2-hydroxyethyl-
amino)-6-benzylamino-9-isopropylpurine) used in this study was purchased 
from Enzo Life Sciences, Inc. A 10-mM stock solution was prepared in DMSO 
and used at 10 µM for in vitro kinase assays, cell proliferation, and cell migra-
tion assays and in the range of 5 to 80 µM for cell viability assays.
Western blot analyses. Tissue or cell lysates were prepared in RIPA buffer 
(Thermo Fisher Scientific) containing a protease inhibitor cocktail tablet 
(Roche) as well as phosphatase inhibitor cocktail I and II (Sigma-Aldrich). 
Proteins were denatured by heating for 10 min at 95°C in sample buffer (2% 
SDS, 10% glycerol, 80 mM Tris, pH 6.8, and 1 mM DTT, and 50–100 µg of 
proteins were electrophoresed in 4–20% bis-Tris/polyacrylamide gels (Invit-
rogen). Proteins were then transferred to 0.2-µm nitrocellulose membranes 
(Invitrogen), which were then blocked for 2 h in blocking solution (TBS 
containing 10% nonfat dry milk and 0.05% Tween 20) and incubated over-
night at 4°C with primary antibody diluted in blocking solution. On the 
next day, membranes were probed with horseradish peroxidase–conjugated 
secondary antibody for 1 h at room temperature, and immunoreactivity was 
detected by using enhanced chemiluminescence (Thermo Fisher Scientific).
Immunoprecipitation  assays.  Protein  lysates  (at  the  concentration  of   
1 µg/µl) were prepared from Cdk5+/+C and Cdk5/C lymphocytes collected 
from mice 4 wk after the induction of EAE. Lysates were precleared with JEM VOL. 207, October 25, 2010 
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Online supplemental material. Fig. S1 shows suppression of antigen re-
ceptor-mediated lymphocyte activation by roscovitine treatment. Fig. S2 
shows the strategy for the generation of immune chimeric mice and presents 
the immunophenotyping data demonstrating no difference among Cdk5+/+ 
and Cdk5/, p35+/+ and p35/, and Cdk5+/+C and Cdk5/C at baseline. 
Fig. S3 shows representative sections of immunostaining performed to char-
acterize immune cell infiltrates in spinal cord after EAE induction. Fig. S4 
shows the mass spectrometry2 spectrum and identification of coronin 1a with 
peptide mapping. Fig. S5 shows the results of immunostaining for Arp2/3 
and F-actin in encephalitogenic lymphocytes revealing normal Arp2/3 po-
larization in lymphocytes from the Cdk5/C mice. Fig. S6 provides results 
of transmigration assays in which migration of Jurkat cells toward CCL19 
is suppressed in the presence of roscovitine. Fig. S7 shows the results of as-
says of in vitro cytokine production by encephalitogenic splenocytes, during 
both the active and chronic phase of disease, after restimulation with MOG 
(35–55) ex vivo. Online supplemental material is available at http://www 
.jem.org/cgi/content/full/jem.20100876/DC1.
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